PMC/PhRMA Report: Biopharmaceutical Companies’ Personalized Medicine Research

Biopharmaceutical Companies' Personalized Medicine Research Yields Innovative Treatments for Patients (PDF)


Biopharmaceutical Companies' Investment in Personalized MedicineThis document, which is based on research sponsored by PMC and conducted by the Tufts Center for the Study of Drug Development (CSDD), confirms the biopharmaceutical sector's commitment to personalized medicine. It demonstrates that although the sector is making significant progress, it still faces scientific, regulatory and reimbursement barriers as well as challenges regarding clinical adoption in its efforts to get targeted therapies through development and to patients. 

Join Today

PMC members shape and advance the future of personalized medicine.
Join Today